EUR USD GBP
+353-1-416-8900REST OF WORLD
1-800-526-8630U.S. (TOLL FREE)

The World Market for Antibiotics Excluding Medicaments: A 2016 Global Trade Perspective

  • ID: 3281195
  • Report
  • June 2015
  • Region: Global
  • 219 pages
  • ICON Group International
1 of 3
This report was created for strategic planners, international executives and import/export managers who are concerned with the market for antibiotics excluding medicaments. With the globalization of this market, managers can no longer be contented with a local view. Nor can managers be contented with out-of-date statistics that appear several years after the fact. I have developed a methodology, based on macroeconomic and trade models, to estimate the market for antibiotics excluding medicaments for those countries serving the world market via exports or supplying from various countries via imports. I do so for the current year based on a variety of key historical indicators and econometric models.

On the demand side, exporters and strategic planners approaching the world market face a number of questions. Which countries are supplying antibiotics excluding medicaments? What is the dollar value of these imports? How much do the imports of antibiotics excluding medicaments vary from one country to another? Do exporters serving the world market have similar market shares across the importing countries? Which countries supply the most exports of antibiotics excluding medicaments? Which countries are buying their exports? What is the value of these exports and which countries are the largest buyers?

In what follows, Chapter 2 begins by summarizing the regional markets for imported and exported antibiotics excluding medicaments. The total level of imports and exports on a worldwide basis, and those for each region, is based on a model which aggregates across over 150 key country markets and projects these to the current year. From there, each country represents a percent of the world market. This market is served from a number of competitive countries of origin. Based on both demand- and supply-side dynamics, market shares by country of origin are then calculated across each country market destination. These shares lead to a volume of import and export values for each country and are aggregated to regional and world totals. In doing so, we are able to obtain maximum likelihood estimates of both the value of each market and the shares that countries are likely to receive this year. From these figures, rankings are calculated to allow managers to prioritize markets. In this way, all the figures provided in this report are forecasts that can be combined with internal information for strategic planning purposes.

After the worldwide summary in Chapter 2 of both imports and exports, Chapter 3 details the exports of antibiotics excluding medicaments, for each individual country. Chapter 4 does the same, but for imports of antibiotics excluding medicaments for all countries in the world. In all cases, the total dollar volume and percentage share values by major trading partner are provided. Combined, Chapters 3 and 4 present the complete picture for imports and exports of antibiotics excluding medicaments to and from all major countries in the world. Of the 150 countries considered, if a country is not reported here it is therefore estimated to have only a negligible level of trade in antibiotics excluding medicaments (i.e. their market shares are close or equal to zero percent). "Antibiotics Excluding Medicaments" as a category is defined in this report following the definition given by the United Nations Statistics Division Classification Registry using the Standard International Trade Classification, Revision 3 (SITC, Rev. 3). The SITC code that defined "antibiotics excluding medicaments" is 5413.

Important Caveat. The figures should be seen as market estimates, as opposed to historical records, as these are forecasted for the current year of trade. More importantly, in light of the fact that unforeseeable factors might interrupt markets in achieving their reported levels, the figures should be seen as estimates of potential. For example, "mad cow" disease, foot-and-mouth disease, trade embargoes, labor disputes, military conflicts, acts of terrorism and other events will certainly affect the actual trade flows recorded for a variety of industry or product categories. In such cases, the difference between the numbers given in this report and the numbers actually observed might be interpreted as the "net loss" or "net gain" due to these exogenous events affecting regular trade flows that would have occurred had these events not have taken place.

This report was created for the market for antibiotics excluding medicaments.

The World Market for Adrenal Cortical Hormones and Derivatives: A 2016 Global Trade Perspective
The World Market for Antibiotics Excluding Medicaments: A 2016 Global Trade Perspective
The World Market for Blood-Grouping Reagents: A 2016 Global Trade Perspective
The World Market for Caffeine and Its Salts: A 2016 Global Trade Perspective
The World Market for Cinchona Alkaloids, Their Derivatives, and Salts Thereof: A 2016 Global Trade Perspective
The World Market for Diagnostic Reagents and Opacifying Preparations for X-Ray Examinations: A 2016 Global Trade Perspective
The World Market for Ephedrines and Their Salts: A 2016 Global Trade Perspective
The World Market for Glycosides, Glands or Other Organs and Extracts, Antisera, Vaccines, and Similar Products: A 2016 Global Trade Perspective
The World Market for Human Blood, Prepared Animal Blood, Toxins, Cultures of Micro-Organisms, and Similar Products Excluding Yeasts: A 2016 Global Trade Perspective
The World Market for Insulin and Its Salts: A 2016 Global Trade Perspective
The World Market for Medicaments Containing Adrenal Cortical Hormones in Measured Doses or in Forms or Packings for Retail Sale: A 2016 Global Trade Perspective
The World Market for Medicaments Containing Antibiotics (Except Penicillins and Streptomycins) Excluding Those in Dosage Form or Retail Packings: A 2016 Global Trade Perspective
The World Market for Medicaments Containing Antibiotics in Dosage Form or Retail Packings Excluding Penicillins and Streptomycins: A 2016 Global Trade Perspective
The World Market for Medicaments Containing Antibiotics or Their Derivatives: A 2016 Global Trade Perspective
The World Market for Medicaments Containing Hormones, Their Derivatives, and Other Steriods Used as Hormones Excluding Antibiotics and Their Derivatives: A 2016 Global Trade Perspective
The World Market for Medicaments Containing Insulin Excluding Those in Dosage Form or Retail Packings: A 2016 Global Trade Perspective
The World Market for Medicaments Containing Insulin in Dosage Form or Retail Packings: A 2016 Global Trade Perspective
The World Market for Medicaments Containing Penicillins or Streptomycins or Their Derivatives in Dosage Form or Retail Packings: A 2016 Global Trade Perspective
The World Market for Medicaments Containing Penicillins, Streptomycins, or Their Derivatives Excluding Those in Dosage Form or Retail Packings: A 2016 Global Trade Perspective
The World Market for Medicaments Containing Vitamins or Provitamins in Dosage Form or Retail Packings: A 2016 Global Trade Perspective
The World Market for Natural or Synthetic Glycosides and Their Salts, Ethers, Esters, and Other Derivatives: A 2016 Global Trade Perspective
The World Market for Natural or Synthetic Hormones, Hormone Derivatives, and Other Steriods Used as Hormones Excluding Medicaments: A 2016 Global Trade Perspective
The World Market for Nicotine and Its Salts: A 2016 Global Trade Perspective
The World Market for Opium Alkaloids, Their Derivatives, and Salts Thereof: A 2016 Global Trade Perspective
The World Market for Penicillins and Derivatives with a Penicillanic Acid Structure and Salts Thereof: A 2016 Global Trade Perspective
The World Market for Pharmaceutical Goods Excluding Medicaments: A 2016 Global Trade Perspective
The World Market for Pituitary (Anterior) or Similar Hormones and Derivatives: A 2016 Global Trade Perspective
The World Market for Provitamin, Vitamin Intermixtures, and Natural Concentrates: A 2016 Global Trade Perspective
The World Market for Provitamins and Vitamins Excluding Medicaments: A 2016 Global Trade Perspective
The World Market for Rye Ergot Alkaloids, Their Derivatives, and Salts Thereof: A 2016 Global Trade Perspective
The World Market for Streptomycins, Derivatives, and Salts: A 2016 Global Trade Perspective
The World Market for Tetracyclines, Derivatives, and Salts Thereof: A 2016 Global Trade Perspective
The World Market for Theophylline and Aminophylline (Theophylline-Ethylenediamine), Their Derivatives, and Salts Thereof: A 2016 Global Trade Perspective
The World Market for Unmixed Provitamins: A 2016 Global Trade Perspective
The World Market for Unmixed Vitamin C and Derivatives: A 2016 Global Trade Perspective
The World Market for Unmixed Vitamin E and Derivatives: A 2016 Global Trade Perspective
The World Market for Unmixed Vitamins A and Derivatives: A 2016 Global Trade Perspective
The World Market for Unmixed Vitamins B and Derivatives: A 2016 Global Trade Perspective
The World Market for Vaccines, Antisera, and Other Blood Fractions: A 2016 Global Trade Perspective
The World Market for Vegetable Alkaloids and Their Salts, Ethers, Esters and Other Derivatives Excluding Medicaments: A 2016 Global Trade Perspective
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1 METHODOLOGY
1.1 Our Approach
2 THE WORLD MARKET
2.1 Exports
2.1.1 The World Market: Antibiotics Excluding Medicaments Export Supplies in 2016
2.2 Imports
2.2.1 The World Market: Imported Antibiotics Excluding Medicaments in 2016
3 EXPORTS
3.1 Africa: Export Supplies of Antibiotics Excluding Medicaments
3.1.1 Executive Summary
3.1.2 Cameroon
3.1.3 Congo (formerly Zaire)
3.1.4 Egypt
3.1.5 Kenya
3.1.6 Mauritius
3.1.7 Morocco
3.1.8 Sierra Leone
3.1.9 South Africa
3.1.10 Swaziland
3.1.11 Tanzania
3.1.12 Togo
3.2 Asia: Export Supplies of Antibiotics Excluding Medicaments
3.2.1 Executive Summary
3.2.2 Bangladesh
3.2.3 China
3.2.4 Hong Kong
3.2.5 India
3.2.6 Indonesia
3.2.7 Japan
3.2.8 Macau
3.2.9 Malaysia
3.2.10 North Korea
3.2.11 Philippines
3.2.12 Singapore
3.2.13 South Korea
3.2.14 Taiwan
3.2.15 Thailand
3.2.16 Vietnam
3.3 Europe: Export Supplies of Antibiotics Excluding Medicaments
3.3.1 Executive Summary
3.3.2 Albania
3.3.3 Austria
3.3.4 Belgium
3.3.5 Bulgaria
3.3.6 Croatia
3.3.7 Cyprus
3.3.8 Czech Republic
3.3.9 Denmark
3.3.10 Finland
3.3.11 France
3.3.12 Germany
3.3.13 Greece
3.3.14 Hungary
3.3.15 Iceland
3.3.16 Ireland
3.3.17 Italy
3.3.18 Latvia
3.3.19 Lithuania
3.3.20 Luxembourg
3.3.21 Malta
3.3.22 Norway
3.3.23 Poland
3.3.24 Portugal
3.3.25 Romania
3.3.26 Russia
3.3.27 Slovakia
3.3.28 Slovenia
3.3.29 Spain
3.3.30 Sweden
3.3.31 Switzerland
3.3.32 the Netherlands
3.3.33 the United Kingdom
3.3.34 Ukraine
3.4 Latin America: Export Supplies of Antibiotics Excluding Medicaments
3.4.1 Executive Summary
3.4.2 Argentina
3.4.3 Brazil
3.4.4 Chile
3.4.5 Colombia
3.4.6 Costa Rica
3.4.7 Ecuador
3.4.8 El Salvador
3.4.9 Guatemala
3.4.10 Mexico
3.4.11 Panama
3.4.12 Peru
3.4.13 Suriname
3.4.14 Uruguay
3.4.15 Venezuela
3.5 North America & the Caribbean: Export Supplies of Antibiotics Excluding Medicaments
3.5.1 Executive Summary
3.5.2 Antigua and Barbuda
3.5.3 Canada
3.5.4 Dominica
3.5.5 Jamaica
3.5.6 the Netherlands Antilles
3.5.7 the United States
3.6 Oceana: Export Supplies of Antibiotics Excluding Medicaments
3.6.1 Executive Summary
3.6.2 Australia
3.6.3 New Zealand
3.7 the Middle East: Export Supplies of Antibiotics Excluding Medicaments
3.7.1 Executive Summary
3.7.2 Iran
3.7.3 Israel
3.7.4 Jordan
3.7.5 Oman
3.7.6 Pakistan
3.7.7 Saudi Arabia
3.7.8 Syrian Arab Republic
3.7.9 the United Arab Emirates
3.7.10 Turkey
4 IMPORTS
4.1 Africa: Antibiotics Excluding Medicaments Imports in 2016
4.1.1 Executive Summary
4.1.2 Algeria
4.1.3 Botswana
4.1.4 Burundi
4.1.5 Cameroon
4.1.6 Cape Verde
4.1.7 Cote d'Ivoire
4.1.8 Egypt
4.1.9 Ethiopia
4.1.10 Ghana
4.1.11 Kenya
4.1.12 Mauritius
4.1.13 Morocco
4.1.14 Mozambique
4.1.15 Nigeria
4.1.16 Sao Tome E Principe
4.1.17 South Africa
4.1.18 Tanzania
4.1.19 Tunisia
4.1.20 Uganda
4.1.21 Zambia
4.1.22 Zimbabwe
4.2 Asia: Antibiotics Excluding Medicaments Imports in 2016
4.2.1 Executive Summary
4.2.2 Bhutan
4.2.3 Cambodia
4.2.4 China
4.2.5 Hong Kong
4.2.6 India
4.2.7 Indonesia
4.2.8 Japan
4.2.9 Malaysia
4.2.10 Nepal
4.2.11 Philippines
4.2.12 Singapore
4.2.13 South Korea
4.2.14 Sri Lanka
4.2.15 Taiwan
4.2.16 Thailand
4.3 Europe: Antibiotics Excluding Medicaments Imports in 2016
4.3.1 Executive Summary
4.3.2 Albania
4.3.3 Austria
4.3.4 Belarus
4.3.5 Belgium
4.3.6 Bosnia and Herzegovina
4.3.7 Bulgaria
4.3.8 Croatia
4.3.9 Cyprus
4.3.10 Czech Republic
4.3.11 Denmark
4.3.12 Estonia
4.3.13 Finland
4.3.14 France
4.3.15 Georgia
4.3.16 Germany
4.3.17 Greece
4.3.18 Hungary
4.3.19 Ireland
4.3.20 Italy
4.3.21 Kazakhstan
4.3.22 Latvia
4.3.23 Lithuania
4.3.24 Moldova
4.3.25 Norway
4.3.26 Poland
4.3.27 Portugal
4.3.28 Romania
4.3.29 Russia
4.3.30 Slovakia
4.3.31 Slovenia
4.3.32 Spain
4.3.33 Sweden
4.3.34 Switzerland
4.3.35 the Netherlands
4.3.36 the United Kingdom
4.3.37 Ukraine
4.4 Latin America: Antibiotics Excluding Medicaments Imports in 2016
4.4.1 Executive Summary
4.4.2 Argentina
4.4.3 Bolivia
4.4.4 Brazil
4.4.5 Chile
4.4.6 Colombia
4.4.7 Costa Rica
4.4.8 Ecuador
4.4.9 El Salvador
4.4.10 Guatemala
4.4.11 Guyana
4.4.12 Mexico
4.4.13 Nicaragua
4.4.14 Panama
4.4.15 Paraguay
4.4.16 Peru
4.4.17 Venezuela
4.5 North America & the Caribbean: Antibiotics Excluding Medicaments Imports in 2016
4.5.1 Executive Summary
4.5.2 Bermuda
4.5.3 Canada
4.5.4 Dominican Republic
4.5.5 Jamaica
4.5.6 the United States
4.6 Oceana: Antibiotics Excluding Medicaments Imports in 2016
4.6.1 Executive Summary
4.6.2 Australia
4.6.3 New Zealand
4.7 the Middle East: Antibiotics Excluding Medicaments Imports in 2016
4.7.1 Executive Summary
4.7.2 Armenia
4.7.3 Azerbaijan
4.7.4 Bahrain
4.7.5 Iran
4.7.6 Israel
4.7.7 Jordan
4.7.8 Kyrgyzstan
4.7.9 Lebanon
4.7.10 Oman
4.7.11 Pakistan
4.7.12 Saudi Arabia
4.7.13 the United Arab Emirates
4.7.14 Turkey
5 DISCLAIMERS, WARRANTEES, AND USER AGREEMENT PROVISIONS
5.1 Disclaimers & Safe Harbor
5.2 ICON Group International, Inc. User Agreement Provisions
Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown
Adroll
adroll